Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
31.21
-0.10 (-0.32%)
At close: Oct 23, 2026, 4:00 PM EDT
31.21
0.00 (0.00%)
After-hours: Oct 23, 2026, 4:37 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.42 billion as of October 23, 2026. It is the 3,382nd most valuable company in the world and the 1,101st biggest in the United States. Its market cap has increased by 160.98% in one year.
Market Cap
5.42B
Enterprise Value
4.87B
1-Year Change
160.98%
Global Rank
Country Rank
#1,101 United States
Category
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.42B, an increase of 4,259.09%. That is a compound annual growth rate of 82.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.42B | 0.25% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.05B |
| Belite Bio | 5.95B |
| Immunovant | 5.87B |
| Veradermics | 5.83B |
| Kodiak Sciences | 5.49B |
| CG Oncology | 5.47B |
| Oruka Therapeutics | 5.31B |
| Mirum Pharmaceuticals | 5.22B |